Published On Dec 20, 2019
Dr. Fabrizio De Benedetti describes use of cytokine-targeted therapies in macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH).
show more
Dr. Fabrizio De Benedetti describes use of cytokine-targeted therapies in macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH).
